| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2010 | US20100035836 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 02/11/2010 | US20100035835 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 02/11/2010 | US20100035834 Novel 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof |
| 02/11/2010 | US20100035833 Antibiotic macrocycle compounds and methods of mnaufacture and use thereof |
| 02/11/2010 | US20100035832 Macrolides |
| 02/11/2010 | US20100035831 Anti-wrinkle agent and adam inhibitor |
| 02/11/2010 | US20100035830 Iron-Carbohydrate Complex Compounds |
| 02/11/2010 | US20100035829 Method of treating intrauterine inflammation |
| 02/11/2010 | US20100035828 Milk oligosaccharide for stimulating the immune system |
| 02/11/2010 | US20100035827 Multivalent metal salts of boronic acids |
| 02/11/2010 | US20100035826 Controlled release of phenolic opioids |
| 02/11/2010 | US20100035811 Phosphoinositide Modulation For The Treatment Of Neurodegenerative Diseases |
| 02/11/2010 | US20100035808 Methods and compositions for promoting organ development |
| 02/11/2010 | US20100035807 Composition and method for treatment of tumors |
| 02/11/2010 | US20100035804 Polypeptide antagonist |
| 02/11/2010 | US20100035801 Method for accelerating cutaneous barrier recovery |
| 02/11/2010 | US20100035799 Method for the synthesis of anthracycline-peptide conjugates |
| 02/11/2010 | US20100035796 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 02/11/2010 | US20100035793 Modulators |
| 02/11/2010 | US20100035329 recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts converts hydroxymethylglutaryl-CoA to mevalonic acid, mevalonic acid to phosphomevalonic acid, phosphomevalonic acid to phosphomevalonate, phosphomevalonate to isopentenyl pyrophosphate |
| 02/11/2010 | US20100034904 Composition comprisong rutin and polyunsaturated fatty acid having an inhibitory activity on 5-alph reductase |
| 02/11/2010 | US20100034902 Method for the diagnosis and treatment of salt sensitivity and related conditions |
| 02/11/2010 | US20100034901 Animal feed compositions |
| 02/11/2010 | US20100034895 Methods of treatment using a gastric retained gabapentin dosage |
| 02/11/2010 | US20100034894 Use of Sucralose as a Granulating Agent |
| 02/11/2010 | US20100034891 Taste-masking solid preparation of pioglitazone |
| 02/11/2010 | US20100034890 Combinations of formoterol and fluticasone propionate for asthma |
| 02/11/2010 | US20100034888 Granulate containing a pharmaceutically active substance and method for its manufacture |
| 02/11/2010 | US20100034887 Bursting Pellets |
| 02/11/2010 | US20100034885 Formulations containing glimepiride and/or its salts |
| 02/11/2010 | US20100034879 Hyaluronic acid product and method for treating lacerations and wounds in a living body |
| 02/11/2010 | US20100034878 Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy |
| 02/11/2010 | US20100034876 Controlled release oxycodone compositions |
| 02/11/2010 | US20100034873 Transdermal ricinoleic acid compositions |
| 02/11/2010 | US20100034867 Drug delivery coating for use with a medical device and methods of treating vascular injury |
| 02/11/2010 | US20100034862 Covalently grafted pharmaceutically active polymers |
| 02/11/2010 | US20100034845 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 02/11/2010 | US20100034838 Transdermal Administration of Active Agents for Systemic Effect |
| 02/11/2010 | US20100034837 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 02/11/2010 | US20100034835 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma |
| 02/11/2010 | US20100034832 Methods for manipulating stem cells |
| 02/11/2010 | US20100034827 Novel hiv reverse transcriptase inhibitors |
| 02/11/2010 | US20100034822 Haemophilus Influenzae Type B |
| 02/11/2010 | US20100034819 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia |
| 02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 02/11/2010 | US20100034810 Pyrimidine derivatives for the prevention of hiv infection |
| 02/11/2010 | US20100034808 Compositions and methods for preserving cells of the eye |
| 02/11/2010 | US20100034806 Methods and Compositons for the Treatment of Marfan Syndrome and Associated Disorders |
| 02/11/2010 | US20100034801 Non-Polymeric Compositions for Controlled Drug Delivery |
| 02/11/2010 | US20100034798 Composition and method of use for intestinal health |
| 02/11/2010 | US20100034796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
| 02/11/2010 | US20100034795 Use of l-carnitine or alkanyl l-carnitine for the preparation of a dietary supplement or medicament for the treatment of corneal disease |
| 02/11/2010 | US20100034789 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 02/11/2010 | US20100034788 Method for diagnosing and treating bone-related diseases |
| 02/11/2010 | US20100034784 inhibiting neuronal death, inducing proliferation and differentiation of a neuronal progenitor cell into a neuron and increasing the number of neurons, in humans |
| 02/11/2010 | US20100034781 Oxysterol Compounds and the Hedgehog Pathway |
| 02/11/2010 | US20100034777 Method for Regulating Protein Function in Cells In Vivo Using Synthetic Small Molecules |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | US20100034773 5,6-dihydro-1h-pyridin-2-one compounds |
| 02/11/2010 | US20100034772 Compositions and methods for immunotherapy |
| 02/11/2010 | US20100034769 Compositions for tissue augmentation |
| 02/11/2010 | US20100034768 Composition and method for treatment of insect bites |
| 02/11/2010 | US20100034767 Composition for making up the lips |
| 02/11/2010 | US20100034762 Novel enrichment methods for gallic acid esters including 1-O-galloy1-bata-D-glucose and mucic acid gallates medicaments, therapeutic applications and methods of treatment thereof |
| 02/11/2010 | US20100034752 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same |
| 02/11/2010 | US20100034749 Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases |
| 02/11/2010 | US20100034745 Method for Reducing Levels of Disease Associated Proteins |
| 02/11/2010 | US20100034744 Method For Screening Anti-HIV Drugs and A Diagnostic Method of AIDS |
| 02/11/2010 | US20100034741 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
| 02/11/2010 | US20100034736 Identification of cancer stem cells using genetic markers |
| 02/11/2010 | US20100034696 Ciclesonide-containing sterile aqueous suspension |
| 02/11/2010 | US20100032374 Phosphate binding materials and their uses |
| 02/11/2010 | DE202009009917U1 Ambrisentan in spezifischer kristalliner Form Ambrisentan in specific crystalline form |
| 02/11/2010 | DE102008041049A1 Use of a composition comprising one or more of methacrylic acid and methacrylic acid ester as a medicament for topical treatment of fungal disease of the foot and/or fingernails |
| 02/11/2010 | DE102008037025A1 Kristalline Wirkstoff-Mikropartikel, Verfahren zu deren Herstellung und Verwendung in Arzneimitteln Crystalline drug microparticles, methods for their preparation and use in medicaments |
| 02/11/2010 | DE102008036825A1 Schwangerschaftsvermeidung durch Gestagene Pregnancy prevention by progestins |
| 02/11/2010 | DE102008036725A1 Pharmazeutische Zusammensetzung für die nasale Applikation A pharmaceutical composition for nasal administration |
| 02/11/2010 | CA2738866A1 Flupirtine hydrochloride maleic acid cocrystal |
| 02/11/2010 | CA2735393A1 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture |
| 02/11/2010 | CA2733499A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | CA2733458A1 Lipid compounds for suppression of tumorigenesis |
| 02/11/2010 | CA2733440A1 Respiratory disease treatment |
| 02/11/2010 | CA2733430A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | CA2733380A1 Quinuclidine carbonate derivatives and medicinal composition thereof |
| 02/11/2010 | CA2733378A1 Pde10 inhibitors and related compositions and methods |
| 02/11/2010 | CA2733237A1 Oral formulations of chemotherapeutic agents |
| 02/11/2010 | CA2733235A1 Crystalline forms of a pyridine derivative |
| 02/11/2010 | CA2733231A1 Sustained release compositions comprising gums and sugar alcohols |
| 02/11/2010 | CA2733228A1 Conjugated suramin amino compounds for medical conditions |
| 02/11/2010 | CA2733203A1 Use of mtor inhibitors to enhance t cell immune responses |
| 02/11/2010 | CA2733176A1 Pyrazolo [5,1-b] oxazole derivatives as crf1 antagonists |
| 02/11/2010 | CA2733159A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 02/11/2010 | CA2733153A1 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/11/2010 | CA2733149A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 02/11/2010 | CA2733105A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| 02/11/2010 | CA2733059A1 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 02/11/2010 | CA2733057A1 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/11/2010 | CA2732950A1 Imidazopyridin-2-one derivatives |
| 02/11/2010 | CA2732932A1 Organic compounds |
| 02/11/2010 | CA2732928A1 Hyaluronic acid-based gels including anesthetic agents |